PM
EVH icon

Parametrica Management’s Evolent Health EVH Stock Holding History

Parametrica Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,806
Closed -$222K – 282
2018
Q3 		$222K Buy
+7,806
New +$186K 0.49% 118
2017
Q4 		– Sell
-13,359
Closed -$238K – 391
2017
Q3 		$238K Buy
+13,359
New +$275K 0.1% 269

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Parametrica Management's EVH Position: Q4 2018 in Review

Parametrica Management sold out of Evolent Health (EVH) in Q4 2018, closing a stake of 7,806 shares — an estimated $222K sold.

Parametrica Management first reported a position in EVH in Q3 2017 and held it in 2 quarters. The position peaked at $238K in Q3 2017. 186 funds tracked by Wall St. Rank hold EVH as of Q4 2018.

  • Parametrica Management reported no remaining Evolent Health position as of Q4 2018 after selling out during the quarter.
  • Parametrica Management sold 7,806 Evolent Health shares in Q4 2018, an estimated $222K.
  • Parametrica Management first reported a position in Evolent Health in Q3 2017 and held it in 2 quarters.
  • Parametrica Management's Evolent Health position peaked at $238K in Q3 2017.
  • 186 funds tracked by Wall St. Rank held Evolent Health as of Q4 2018.

Based on Parametrica Management's 13F filing for Q4 2018, filed 12 Feb 2019.